{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": 1.7784985, "regularMarketPrice": 50.36, "exchange": "NMS", "shortName": "Vaxcyte, Inc.", "longName": "Vaxcyte, Inc.", "messageBoardId": "finmb_307500026", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "firstTradeDateMilliseconds": 1591968600000, "priceHint": 2, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.4, "epsForward": -3.4, "epsCurrentYear": -3.08, "priceEpsCurrentYear": -16.35065, "sharesOutstanding": 93063696, "bookValue": 11.716, "fiftyDayAverage": 41.651, "fiftyDayAverageChange": 8.709, "fiftyDayAverageChangePercent": 0.2090946, "twoHundredDayAverage": 37.94885, "twoHundredDayAverageChange": 12.411152, "twoHundredDayAverageChangePercent": 0.3270495, "marketCap": 4990887424, "forwardPE": -14.811765, "priceToBook": 4.2983956, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 0.88000107, "regularMarketTime": 1684180805, "regularMarketDayHigh": 50.8, "regularMarketDayRange": "49.63 - 50.8", "regularMarketDayLow": 49.63, "regularMarketVolume": 590320, "regularMarketPreviousClose": 49.48, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 8, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 49.87, "averageDailyVolume3Month": 993148, "averageDailyVolume10Day": 795220, "fiftyTwoWeekLowChange": 32.92, "fiftyTwoWeekLowChangePercent": 1.8876145, "fiftyTwoWeekRange": "17.44 - 54.838", "fiftyTwoWeekHighChange": -4.4780006, "fiftyTwoWeekHighChangePercent": -0.08165871, "fiftyTwoWeekLow": 17.44, "fiftyTwoWeekHigh": 54.838, "earningsTimestamp": 1683576000, "earningsTimestampStart": 1691405940, "displayName": "Vaxcyte", "symbol": "PCVX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "825 Industrial Road", "address2": "Suite 300", "city": "San Carlos", "state": "CA", "zip": "94070", "country": "United States", "phone": "650 837 0111", "website": "https://vaxcyte.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against these emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Mr. Grant E. Pickering M.B.A.", "age": 54, "title": "Co-Founder, CEO & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 1102891, "fmt": "1.1M", "longFmt": "1,102,891"}, "exercisedValue": {"raw": 5665843, "fmt": "5.67M", "longFmt": "5,665,843"}, "unexercisedValue": {"raw": 32005802, "fmt": "32.01M", "longFmt": "32,005,802"}}, {"maxAge": 1, "name": "Mr. Andrew L. Guggenhime M.B.A.", "age": 54, "title": "Pres & CFO", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 839653, "fmt": "839.65k", "longFmt": "839,653"}, "exercisedValue": {"raw": 2365139, "fmt": "2.37M", "longFmt": "2,365,139"}, "unexercisedValue": {"raw": 13047514, "fmt": "13.05M", "longFmt": "13,047,514"}}, {"maxAge": 1, "name": "Mr. James  Wassil M.B.A., M.S.", "age": 53, "title": "Exec. VP & COO", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 826298, "fmt": "826.3k", "longFmt": "826,298"}, "exercisedValue": {"raw": 506183, "fmt": "506.18k", "longFmt": "506,183"}, "unexercisedValue": {"raw": 6547650, "fmt": "6.55M", "longFmt": "6,547,650"}}, {"maxAge": 1, "name": "Mr. Mikhail  Eydelman J.D.", "age": 41, "title": "Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": {"raw": 793217, "fmt": "793.22k", "longFmt": "793,217"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul W. Sauer M.B.A., MBA", "age": 61, "title": "Sr. VP of Process Devel. & Manufacturing", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 608956, "fmt": "608.96k", "longFmt": "608,956"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 6361555, "fmt": "6.36M", "longFmt": "6,361,555"}}, {"maxAge": 1, "name": "Dr. Ashish  Khanna M.B.A., Ph.D.", "age": 50, "title": "Co-Founder", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jeff  Fairman Ph.D.", "age": 58, "title": "Co-Founder & VP of Research", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Elvia  Cowan", "age": 49, "title": "Sr. VP of Fin. & Principal Accounting Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Janet  Graesser", "title": "VP of Corp. Communications & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Karen  Alderete", "title": "Exec. Director of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 6, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}